These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8103784

  • 1. [Evaluation of the degree of biological behavior in endometrial hyperplasia and endometrial carcinoma: an investigation of proliferative activity, oncogene, and extracellular matrix].
    Sato S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):776-88. PubMed ID: 8103784
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Aug; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 3. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C, Dallenbach-Hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J.
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [Abstract] [Full Text] [Related]

  • 5. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
    Ashihara K, Saito T, Mizumoto H, Nishimura M, Tanaka R, Kudo R.
    Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
    [Abstract] [Full Text] [Related]

  • 6. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF, Liu MQ, Zhao Q.
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [Abstract] [Full Text] [Related]

  • 7. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL.
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [Abstract] [Full Text] [Related]

  • 8. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
    Hareyama H.
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE, Stenbäck F, Tapanainen JS.
    Cancer; 2002 Oct 01; 95(7):1463-71. PubMed ID: 12237915
    [Abstract] [Full Text] [Related]

  • 10. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma].
    Zhou XR, Du XG.
    Zhonghua Fu Chan Ke Za Zhi; 1992 Sep 01; 27(5):278-80, 316. PubMed ID: 1298588
    [Abstract] [Full Text] [Related]

  • 11. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, Fujii S.
    Cancer; 2002 Feb 15; 94(4):997-1005. PubMed ID: 11920468
    [Abstract] [Full Text] [Related]

  • 12. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
    Amălinei C, Căruntu ID, Balan R, Cianga C, Cianga P.
    Rev Med Chir Soc Med Nat Iasi; 2008 Feb 15; 112(2):437-48. PubMed ID: 19295017
    [Abstract] [Full Text] [Related]

  • 13. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP, Choi CM, Polek TC, McBride R, Bigsby RM, Khan SA, Husseinzadeh N.
    Gynecol Oncol; 2000 Mar 15; 76(3):388-96. PubMed ID: 10684716
    [Abstract] [Full Text] [Related]

  • 14. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
    Henderson GS, Brown KA, Perkins SL, Abbott TM, Clayton F.
    Mod Pathol; 1996 Apr 15; 9(4):430-8. PubMed ID: 8729985
    [Abstract] [Full Text] [Related]

  • 15. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
    Obokata A, Watanabe J, Nishimura Y, Arai T, Kawaguchi M, Kuramoto H.
    Anticancer Res; 2007 Apr 15; 27(1A):95-105. PubMed ID: 17352221
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM, Leers MP, Radespiel-Tröger M, Björklund V, Kabarity HE, Nap M, Jäger W.
    Gynecol Oncol; 2000 Apr 15; 77(1):11-7. PubMed ID: 10739685
    [Abstract] [Full Text] [Related]

  • 17. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX, Zhang SL, Gao S, Lu JM, Dong F.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun 15; 41(6):395-8. PubMed ID: 16831363
    [Abstract] [Full Text] [Related]

  • 18. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
    Muslumanoglu HM, Oner U, Ozalp S, Acikalin MF, Yalcin OT, Ozdemir M, Artan S.
    Eur J Obstet Gynecol Reprod Biol; 2005 May 01; 120(1):107-14. PubMed ID: 15866096
    [Abstract] [Full Text] [Related]

  • 19. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
    Taponeco F, Curcio C, Giuntini A, Nardini V, Fornaciari G, Artini PG, D'Ambrogio G, Genazzani AR.
    J Exp Clin Cancer Res; 2001 Jun 01; 20(2):239-46. PubMed ID: 11484981
    [Abstract] [Full Text] [Related]

  • 20. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr 01; 41(4):242-5. PubMed ID: 16759458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.